Trials / Unknown
UnknownNCT05527535
Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand
Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand: An Implementation Research
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 34,500 (estimated)
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Efficiency and effectiveness of real-world diabetic retinopathy screening by artificial intelligent (AI) are limited. Investigators will implement AI for diabetic retinopathy screening in 13 health districts in Thailand and investigate the efficiency, effectiveness as well as patients and health care personnel's satisfaction by an implementation research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diabetic retinopathy screening by artificial intelligence | Screening diabetic patients' eyes with AI through digital health platform |
| DIAGNOSTIC_TEST | Diabetic retinopathy screening by healthcare personnel | Screening diabetic patients' eyes by conventional method (healthcare personnel) |
Timeline
- Start date
- 2022-10-03
- Primary completion
- 2023-03-31
- Completion
- 2023-09-30
- First posted
- 2022-09-02
- Last updated
- 2022-09-02
Source: ClinicalTrials.gov record NCT05527535. Inclusion in this directory is not an endorsement.